HKEX Filings
-
Feb 3, 2023
Monthly Return of Equity Issuer on Movements in Securities for the Month ended January 31, 2023
-
Jan 16, 2023
INSIDE INFORMATION - CLOVER PROVIDES UPDATES ON COVID-19 VACCINE COMMERCIAL LAUNCH AND STRATEGIC PRIORITIES IN 2023
-
Jan 4, 2023
Monthly Return of Equity Issuer on Movements in Securities for the Month ended December 31, 2022
-
Dec 30, 2022
Remuneration Committee - Terms of Reference
-
Dec 16, 2022
(1) GRANT OF OPTIONS AND RSUS (2) AMENDMENT TO VESTING SCHEDULE OF PREVIOUSLY GRANTED RSUS AND (3) AMENDMENT TO THE TRUST DEED
-
Dec 13, 2022
Next Day Disclosure Returns
-
Dec 13, 2022
COMPLETION OF PLACING OF NEW SHARES UNDER GENERAL MANDATE
-
Dec 6, 2022
PLACING OF NEW SHARES UNDER GENERAL MANDATE
-
Dec 5, 2022
VOLUNTARY ANNOUNCEMENT - COVID-19 VACCINE (SCB-2019 (CPG 1018/ALUM)) INCLUDED FOR EMERGENCY USE IN THE PRC
-
Dec 2, 2022
Monthly Return of Equity Issuer on Movements in Securities for the Month ended November 30, 2022
-
Nov 30, 2022
VOLUNTARY ANNOUNCEMENT - CLOVER'S VACCINE CANDIDATE REDUCED HOUSEHOLD TRANSMISSION OF SARS-COV-2 BY 84% IN STUDY PUBLISHED IN CLINICAL INFECTIOUS DISEASES
-
Nov 3, 2022
Monthly Return of Equity Issuer on Movements in Securities for the Month ended October 31, 2022
-
Oct 28, 2022
LIST OF DIRECTORS AND THEIR ROLES AND FUNCTIONS
-
Oct 28, 2022
RESIGNATION OF A NON-EXECUTIVE DIRECTOR AND CHANGE IN COMPOSITION OF THE AUDIT COMMITTEE
-
Oct 14, 2022
TERMINATION OF DISCLOSABLE TRANSACTION IN RELATION TO THE LEASE AGREEMENT
-
Oct 9, 2022
INSIDE INFORMATION - CLOVER PROVIDES UPDATE ON 2022 CORPORATE MILESTONES
-
Oct 5, 2022
Monthly Return of Equity Issuer on Movements in Securities for the Month ended September 30, 2022
-
Sep 20, 2022
VOLUNTARY ANNOUNCEMENT - CLOVER'S COVID-19 VACCINE CANDIDATE RECEIVES EU GMP CERTIFICATE
-
Sep 20, 2022
VOLUNTARY ANNOUNCEMENT - CLOVER'S UNIVERSAL COVID-19 BOOSTER VACCINE CANDIDATE DEMONSTRATES SUPERIOR NEUTRALIZATION OF OMICORN BA.5 COMPARED TO INACTIVATED VACCINE
-
Sep 16, 2022
Notification Letter and Request Form for Non-Registered Shareholders